110
Participants
Start Date
December 16, 2024
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2028
OM-89 [Uro-Vaxom® Capsule]
1st phase and 2nd phase : 1 capsule per day of OM-89 for 90 consecutive days followed by a period of 90 days without treatment, then one capsule per day of OM-89 for 10 consecutive days each month for three months.
OM-89 [Uro-Vaxom® Capsule] OM-89 placebo [Uro-Vaxom® Capsule placebo]
"1st phase: 1 capsule per day of placebo for 90 consecutive days followed by a period of 90 days without treatment, then one capsule per day of placebo for 10 consecutive days each month for three months.~Then 2nd phase: 1 capsule a day of OM-89, for 90 consecutive days followed by a period of 90 days without treatment, then one capsule a day of OM-89 6mg for 10 consecutive days each month for three months."
RECRUITING
CHU Dijon Bourgogne, Dijon
Centre Hospitalier Universitaire Dijon
OTHER